Kevin Marsh, our Executive Director, Commercial Strategy and New Product Development, Patient-Centered Research, will be speaking on an issue panel titled, Should Suboptimal Clinical Evidence be Used to Inform HTA Recommendations? at the CADTH Symposium, an event that brings together members of the health technology management community in Canada and beyond to discuss new ideas, learn best practices, and network with Canadian and international experts.
